Endpoints in respiratory diseases

European Journal of Clinical Pharmacology

Volumn 67, Issue SUPPL. 1, 2011, Pages

  De Benedictis, Fernando Maria ^a   Guidi, Roberto ^a   Carraro, Silvia ^b   Baraldi, Eugenio ^b  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Endpoints; Outcome measures; Respiratory

Indexed keywords

BIOLOGICAL MARKER; EOSINOPHIL CATIONIC PROTEIN; NITRIC OXIDE;

ASTHMA; BRONCHIOLITIS; CLINICAL EFFECTIVENESS; CROUP; CYSTIC FIBROSIS; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; HUMAN; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; REVIEW; SPIROMETRY; SPUTUM EXAMINATION; TREATMENT OUTCOME; VIRAL RESPIRATORY TRACT INFECTION; WHEEZING;

CHILD; CLINICAL TRIALS AS TOPIC; ENDPOINT DETERMINATION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RESPIRATORY TRACT DISEASES; TREATMENT OUTCOME;

EID: 79955604133     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0922-2     Document Type: Review

References (42)

1. Bush A (2006) Evidence-based medicines for children: important implications for new therapies at all ages. Eur Respir J 28:1069-1072
2. Baiardi P, Ceci A, Felisi M, Cantarutti L, Girotto S, Sturkenboom M, Baraldi E (2010) In-label and off-label use of respiratory drugs in the Italian paediatric population. Acta Paediatr 99:544-549
3. Smyth AR, Barbato A, Beydon N, Bisgaard H, de Boeck K, Brand P et al (2010) Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J 35:247-265
4. Spahn J (2003) Clinical trial efficacy: what does it really tell you? J Allergy Clin Immunol 112:S102-S106
5. Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89-95
6. Prentice RL (1989) Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 8:431-440
7. Smyth RL, Openshaw PJ (2006) Bronchiolitis. Lancet 368:312-322 (Pubitemid 44067248)
8. Wainwright C, Altamirano L, Cheney M, Cheney J, Barber S, Price D et al (2003) A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 349:27-35 (Pubitemid 36765100)
9. Gajdos V, Beydon N, Bommenel L, Pellegrino B, de Pontual L, Bailleux S et al (2009) Inter-observer agreement between physicians, nurses, and respiratory therapists for respiratory clinical evaluation in bronchiolitis. Pediatr Pulmonol 44:754-762
10. Plint AC, Johnson DW, Patel H, Wiebe N, Correll R, Brant R et al (2009) Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med 360:2079-2089
11. Lenney W, Boner AL, Bont L, Bush A, Carlsen KH, Eber E et al (2009) Medicines for children used in respiratory diseases only seen in children. Eur Resp J 34:531-551
12. Panickar J, Lakhanpaul M, Lambert PC, Kenia P, Stephenson T, Smyth A, Grigg J (2009) Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med 360:329-338
13. Chalut DS, Ducharme FM, Davis GM (2000) The Preschool Respiratory Assessment Measure (PRAM): a responsive index of acute asthma severity. J Pediatr 137:762-768
14. Ducharme FM, Chalut D, Plotnick L, Savdie C, Kudirka D, Zhang X et al (2008) The Pediatric Respiratory Assessment Measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers. J Pediatr 152:476-480
15. Bacharier LB, Phillips BR, Zeiger RS, Szefler SJ, Martinez FD, Lemanske RF et al (2008) Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol 122:1127-1135
16. Indinnimeo L, Bertuola F, Cutrera R, de Benedictis FM, Di Pietro P, Duse M et al (2009) Clinical evaluation and treatment of acute asthma exacerbations in children. Int J Immunopathol Pharmacol 22:867-878
17. Ferguson C, Gidwani S (2006) Best evidence topic reports. Delivery of bronchodilators in acute asthma in children. Emerg Med J 23:471-472
18. Schuh S, Johnson DW, Stephens D, Callahan S, Winders P, Canny GJ (1999) Comparison of albuterol delivered by a metered dose inhaler with a spacer versus a nebulizer in children with mild acute asthma. J Pediatr 135:22-27 (Pubitemid 30180557)
19. Cates CJ, Bara A, Crilly JA, Rowe BH (2003) Holding chambers versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev: CD000052.
20. Update in: Cochrane Database Syst Rev 2006;(2):CD000052
21. Castro-Rodriguez JA, Rodrigo GJ (2004) Beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbations of wheezing or asthma in children under 5 years of age; a systematic review with metanalysis. J Pediatr 145:172-177
22. Deerojanawong J, Manuyakorn W, Prapphal N, Harnruthakorn C, Sritippayawan S, Samransamruajkit R (2005) Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing. Pediatr Pulmonol 39:466-472 (Pubitemid 40548291)
23. Cherry JD (2008) Croup. N Engl J Med 358:384-391
24. Bjornson CL, Johnson DW (2008) Croup. Lancet 371:329-339 (Pubitemid 351754788)
25. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW et al (2009) American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 180:59-99
26. Pauwels RA, Lofdahl C-G, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A (1997) Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 337:1405-1411 (Pubitemid 27497887)
27. Kerstjens HAM, Brand PLP, Jong PMD, Koeter GH, Postma DS, Dutch CNSLD Study Group (1994) Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. Thorax 49:1109-1115 (Pubitemid 24339820)
28. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR (1999) Development and validation of a questionnaire to measure asthma control. Eur Respir J 14:902-907 (Pubitemid 29519356)
29. Cockcroft DW, Swystun VA (1996) Asthma control versus asthma severity. J Allergy Clin Immunol 98:1016-1018 (Pubitemid 27014791)
30. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P et al (2004) Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 113:59-65 (Pubitemid 38096162)
31. Scichilone N, Deykin A, Pizzichini E, Bellia V, Polosa R (2004) Monitoring response to treatment in asthma management: food for thought. Clin Exp Allergy 34:1168-1177 (Pubitemid 39093054)
32. Covar RA, Spahn JD, Martin RJ, Silkoff PE, Sundstrom DA, Murphy J, Szefler SJ (2004) Safety and application of induced sputum analysis in childhood asthma. J Allergy Clin Immunol 114:575-582 (Pubitemid 39194931)
33. American Thoracic Society, European Respiratory Society (2005) ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171:912-930
34. Horvath I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E et al (2005) Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26:523-548 (Pubitemid 41264218)
35. Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C et al (1999) Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 29:1172-1186 (Pubitemid 29406464)
36. Erickson SR, Kirking DM (2004) Variation in the distribution of patient reported outcomes based on different definitions of defining asthma severity. Curr Med Res Opin 20:1863-1872 (Pubitemid 40179624)
37. Rowe SM, Miller S, Sorscher EJ (2005) Cystic fibrosis. N Engl J Med 352:1992-2001 (Pubitemid 40638370)
38. O'Sullivan BP, Freedman SD (2009) Cystic fibrosis. Lancet 373:1891-1904
39. Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB et al (2006) A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 354:229-240 (Pubitemid 43113028)
40. Rosenfeld M (2007) An overview of endpoints for cystic fibrosis clinical trials: one size does not fit all. Proc Am Thor Soc 4:299-301
41. Quittner AL, Sweeny S, Watrous M, Munzenberger P, Bearss K, Gibson Nitza A et al (2000) Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis. J Pediatr Psychol 25:403-414
42. Davis SD, Brody AS, Emond MJ, Brumback LC, Rosenfeld M (2007) Endpoints for clinical trials in young children with cystic fibrosis. Proc Am Thorac Soc 4:418-430 (Pubitemid 47333916)